Biology of opiates affects prevalence of addiction, options for treatment

Psychiatric Annals

Volumn 33, Issue 9, 2003, Pages 558-564

  Miller, Norman S ^a,b   Lyon, David ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Kalamazoo Center for Medical Studies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; BENZODIAZEPINE; BUPRENORPHINE; CLONIDINE; DIAMORPHINE; DIAZEPAM; DICYCLOVERINE; HYDROCODONE; HYDROXYZINE; IBUPROFEN; LOPERAMIDE; METHADONE; NALTREXONE; OPIATE; OXYCODONE; PARACETAMOL; TRIMETHOBENZAMIDE;

ABDOMINAL PAIN; ANXIETY; DRUG COST; DRUG HALF LIFE; DRUG INTOXICATION; DRUG MARKETING; DRUG MEGADOSE; EUPHORIA; HEADACHE; HUMAN; INSOMNIA; LIMBIC SYSTEM; LIVER TOXICITY; MAXIMUM PERMISSIBLE DOSE; NAUSEA; NONHUMAN; OPIATE ADDICTION; ORTHOSTATIC HYPOTENSION; PREVALENCE; RESPIRATION DEPRESSION; REVIEW; SIDE EFFECT; VOMITING;

EID: 1942467392     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-20030901-06     Document Type: Review

References (15)

1. Karch SB, ed. Drug Abuse Handbook. New York, NY: CRC Press; 1997.
2. Galanter M, Kleber HD. Textbook of Substance Abuse Treatment. 2nd ed. Washington, DC: The American Psychiatric Press; 1999.
3. Office of Applied Studies, Substance Abuse and Mental Health Services Administration. National Household Survey on Drug Abuse. Washington, DC: SAMHSA; 2001.
4. Lu HU, Passik SD, Portenoy RK. Management of chronic pain in the patients with substance abuse. In: Aranoff GM, ed. Evaluation and treatment of chronic pain. 3rd ed. Baltimore, Md: Williams and Wilkins; 1998:421-429.
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders [text revision]. 4th ed. Washington, DC: APA; 1994.
6. Office of Applied Studies, Substance Abuse and Mental Health Services Administration. National Household Survey on Drug Abuse. Washington, DC: SAMHSA; 1999.
7. Warner LA, Kessler RC, Hughes M, Anthony JC, Nelson CB. Prevalence and correlation of drug use and dependence in the United States. Arch Gen Psychology. 1995; 52:219-229.
8. Fe Caces M, Aitken SS. Prescription and nonprescription drug use: A longitudinal study. J of Subst Abuse. 1998;10:115-126.
9. Schuckit MA. Drug and Alcohol Abuse: A Clinical Guide to Diagnosis and Treatment. 5th ed. New York, NY: Kluwer Academic/Plenum Publishers; 2000.
10. Miller NS, Gold MS, Smith DE. Manual of Therapeutics for Addictions. New York, NY: Wiley-Liss, Inc.; 1997.
11. Black RG. The chronic pain syndrome. Surg Clin N Amer. 1975;55:999-1011.
12. Halpern L. Substitution-detoxification and its role in the management of chronic benign pain. J Clin Psychiatry. 1982;43:10-14.
13. Kouyano K, Pither CE, Wessely S. Medication misuse, abuse, and dependence in chronic pain patients. J Psychosomatic Res. 1997; 43:497-504.
14. Fishbain DA, Rosomoff HL, Rosomoff, RS. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain. 1992;8:77-85.
15. Parran T. Prescription drug abuse: a question of balance. Med Clin North Am. 1997;81: 967-978.